Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-03-27Clinical Trial Update: MAGE-A3/12 Metastatic Cancer Treatment With Anti-MAGE-A3/12 TCR-Gene Engineered Lymphocytes [Phase 1, Phase 2]
Phase 1/Phase 2 trial of anti-MAGE-A3/12 TCR-gene engineered lymphocytes in metastatic cancers was terminated. Results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Chemotherapy Followed by Biological Therapy in Treating Patients With Stage IV Melanoma That Cannot be Treated With Surgery [Phase 2]
Phase 2 clinical trial evaluating chemotherapy followed by biological therapy for unresectable Stage IV melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-25Clinical Trial Update: Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal [Phase 1, Phase 2]
This clinical trial update describes a vaccine therapy studied in patients with metastatic melanoma undergoing surgery to remove lymph nodes…
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma [Phase 1]
Phase 1 clinical trial evaluating the combination of Interleukin-12 and Interferon alfa in patients with metastatic renal cell carcinoma and…
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: Modified Tumor Infiltrating Lymphocytes for Metastatic Melanoma [Phase 2]
Phase 2 trial update on modified tumor-infiltrating lymphocytes for metastatic melanoma; trial status is terminated with results posted in 2…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: Anti-MART-1 F5 Lymphocytes to Treat High-Risk Melanoma Patients [Phase 2]
Phase 2 clinical trial evaluating anti-MART-1 F5 lymphocytes for high-risk melanoma has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma [Phase 3]
Phase 3 trial comparing trametinib (GSK1120212) to standard chemotherapy in patients with advanced or metastatic BRAF V600E/K-mutant melanom…
-
FDA approval · 2013-03-13FDA Approved: KIT FOR THE PREPARATION OF LYMPHOSEEK (TECHNETIUM TC 99M TILMANOCEPT) — Original Application (Cardinal Health 414, LLC)
FDA approved the kit for the preparation of Lymphoseek (technetium-99m tilmanocept), enabling production of the radiopharmaceutical used for…
-
CLINICAL_TRIALS trial_result · 2013-03-12Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma [Phase 1]
A Phase 1 trial evaluating a vaccine therapy for stage IIB to stage IV melanoma has completed.
-
CLINICAL_TRIALS withdrawal · 2013-03-07Clinical Trial Update: Study of Immune Responses in Patients With Metastatic Melanoma [Phase 2]
A Phase 2 study evaluating immune responses in patients with metastatic melanoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma [Phase 2]
A Phase 2 trial evaluating the combination of bortezomib, paclitaxel, and carboplatin in patients with metastatic and intraocular melanoma h…
-
CLINICAL_TRIALS trial_result · 2013-03-01Clinical Trial Update: Adoptive Transfer of MART1/Melan-A CTL for Malignant Melanoma [Phase 1]
Phase 1 trial of adoptive transfer of MART1/Melan-A–specific cytotoxic T lymphocytes for malignant melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma [Phase 2]
Phase 2 trial evaluating the combination of erlotinib and bevacizumab in patients with stage IV melanoma; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IV Melanoma [Phase 1]
Phase 1 clinical trial update on a vaccine therapy for stage IV melanoma; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2013-02-26Clinical Trial Update: RAD001 Plus Bevacizumab in Metastatic Melanoma [Phase 2]
Phase 2 trial evaluating RAD001 ( everolimus ) plus bevacizumab in metastatic melanoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors [Phase 1]
Phase 1 trial evaluating a monoclonal antibody therapy for patients with brain tumors and melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Decitabine in Treating Patients With Melanoma or Other Advanced Cancer [Phase 1]
A Phase 1 trial evaluating decitabine in melanoma and other advanced cancers has completed. The study explored safety and dosing across hema…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma [Phase 2]
A Phase 2 trial evaluating the combination of O6-benzylguanine and Carmustine in patients with unresectable locally recurrent or metastatic …
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Thalidomide and SU5416 in Treating Patients With Metastatic Melanoma [Phase 2]
A Phase 2 clinical trial evaluating thalidomide in combination with SU5416 for metastatic melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma [Phase 1]
Phase 1 clinical trial update for a vaccine therapy in unresectable metastatic melanoma; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Vaccine Therapy in Treating Patients With Melanoma [Phase 1]
Phase 1 clinical trial evaluating a melanoma vaccine therapy in patients with melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Decitabine in Treating Patients With Advanced Solid Tumors [Phase 1]
This update reports the completion of a Phase 1 trial of decitabine in patients with advanced solid tumors, including breast, bladder, and m…
-
CLINICAL_TRIALS research · 2013-02-04Clinical Trial Update: A Phase II Study of Imatinib Versus Interferon as Adjuvant Therapy in KIT-mutated Melanoma [Phase 2]
Phase II randomized trial comparing imatinib to interferon as adjuvant therapy for KIT-mutated melanoma; the document provides a trial statu…
-
CLINICAL_TRIALS withdrawal · 2013-01-31Clinical Trial Update: RO4929097 in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma That Can Be Removed by Surgery [Phase 2]
The Phase 2 clinical trial of RO4929097 for surgically removable Stage IIIB/IIIC/Stage IV melanoma sponsored by the NCI has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: BMS-247550 in Treating Patients With Stage IV Melanoma [Phase 2]
Phase 2 trial of BMS-247550 in patients with stage IV (recurrent) melanoma has completed.